ROANOKE, Va., June 22, 2009 (GLOBE NEWSWIRE) -- CMR Institute, the leading independent provider of non-branded education for the pharmaceutical, biotech, and medical device industries, announces that a total of 42 courses and one certificate program have been approved by the District of Columbia's Board of Pharmacy to satisfy the continuing education requirements mandated by Washington, D.C.'s SafeRx Act. SafeRx is the nation's first legislation that requires licensing and continuing education for all pharmaceutical sales representatives who work in Washington, D.C.
The D.C. Board of Pharmacy's latest approval includes 10 NEW streamlined CMRI courses specifically designed to meet the prorated 7.5 CEU requirements for the February 2010 renewal, as well as the 15 CEUS required for subsequent renewals. The approved courses cover key knowledge areas valued by physicians and include anatomy, physiology, disease management, pathology, evidence-based medicine, pharmacology, drug development, therapeutic classes, ethics and compliance; and are delivered in a flexible online format designed to meet the demanding schedules of today's pharmaceutical sales representatives.
"CMR Institute is focused on staying ahead of industry trends and proactively meeting the educational needs of the pharmaceutical industry," says Michelle O'Connor, SVP, Learning Strategy and Innovation. "We're pleased to be the first and, to date, the only independent education provider to have met the District of Columbia's Board of Pharmacy strict criteria for continuing education to satisfy SafeRx requirements."
Also approved is CMRI's 4C Program, an innovative online educational program for representatives resulting in a Pharmaceutical Representative Certificate of Professional Competency. 4C's core competencies were identified from more than two years of in-depth research of physicians' needs and legislative requirements and cover key areas including industry essentials, ethics, science, pharmacology, and bringing value to physicians and patients.
The approved courses are part of CMR Institute's curriculum that educates pharmaceutical, biotech, and medical device representatives, managers, and other professionals. CMR Institute, whose mission is to advance knowledge to enhance healthcare, utilizes a faculty of more than 400 healthcare professionals and leading subject matter experts from 70+ distinguished universities and academic medical centers across the country to develop and maintain an up-to-date curriculum relevant to today's healthcare challenges. Its entire curriculum is regularly reviewed and evaluated to ensure that it meets higher education credit recommendations and contact hours needed and required by various professionals.
Click to read the official SafeRx continuing education approval letter from the D.C. Board of Pharmacy. Click for a complete list of CMR Institute's approved SafeRx continuing education courses.
CMR Institute is the leading independent provider of non-branded education for the pharmaceutical, biotech, and medical device industries and has educated more than 150,000 professionals. Founded in 1966 by physicians in response for a need to increase therapeutic knowledge through scientific education, CMR Institute offers the only nationally recognized certifications for representatives and managers, and its respected programs have defined educational standards. Its expert content is developed and updated by leading industry experts and distinguished thought leaders from prestigious universities and academic medical centers, and includes key education on science, disease management, ethics, and leadership. CMR Institute's not-for-profit status allows it to continually invest its resources in its library of education to realize its mission, which is to advance knowledge to enhance healthcare. To learn more about CMR Institute, visit www.cmrinstitute.org .
The CMR Institute logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=6311